Table: Fuso Pharmaceutical -2021/22 parent results

Fuso Pharmaceutical Industries

11/05/2022 05:40

May 11 (Reuters)- 
          Fuso Pharmaceutical Industries Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2022    Mar 31, 2021   Mar 31, 2023     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           49.63           49.25          50.00        25.00    
               (+0.8 pct)      (+5.0 pct)     (+0.7 pct)    (+0.1 pct) 
  Operating        1.92            2.35           1.60       700 mln   
               (-18.2 pct)    (+132.6 pct)    (-16.8 pct)  (-44.2 pct) 
  Recurring        2.00            2.23           1.60       700 mln   
               (-10.4 pct)    (+108.8 pct)    (-19.9 pct)  (-48.3 pct) 
  Net              1.48            1.61           1.10       500 mln   
               (-7.7 pct)     (+127.3 pct)    (-25.8 pct)  (-52.1 pct) 
  EPS          169.09 yen      183.18 yen     125.39 yen    57.00 yen  
  Ann Div       60.00 yen       60.00 yen      60.00 yen               
  -Q2 Div       30.00 yen       30.00 yen      30.00 yen               
  -Q4 Div       30.00 yen       30.00 yen      30.00 yen               
  
  NOTE - Fuso Pharmaceutical Industries Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4538.T